international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock. Illumina Inc. (NASDAQ: ILMN) today announced the ...

Shares of genomics company Illumina (NASDAQ:ILMN) fell 8.6% in the morning ... on the minds of investors. The stock market ...

If an investor was to purchase shares of ILMN stock at the current price level ... last 250 trading day closing values as well as today's price of $78.86) to be 42%. For more put and call options ...

Momentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or ... companies. ILMN is a #3 ...

Illumina (NASDAQ:ILMN – Get Free Report) had its price objective decreased by stock analysts at Citigroup ... genomic regions of interest. Receive News & Ratings for Illumina Daily - Enter ...

Genomics company Illumina (NASDAQ:ILMN) will be announcing earnings results this Thursday afternoon. Here’s what to expect.

The latest price target for Illumina (NASDAQ:ILMN) was reported by Piper Sandler ... $130 to $100 for Illumina Inc. Analysts arrive at stock ratings after doing extensive research, which includes ...

Grail cutting-edge cancer blood test has stirred investor excitement many times in the past few years. With the stock down 55% from its February peak, Canaccord Genuity issued a Buy recommendation on ...

Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the ... but it doesn't always work for each individual stock. We really hate to see fellow ...